Cao X-Y, Zhang J-P, Zhao Y-L, Xiong M, Zhou J-R, Lu Y, Sun R-J, Wei Z-J, Liu D-Y, Zhang X, et al. Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant. Front Immunol. 2023;14:1191382.